Related Experiment Video

Updated: May 14, 2026

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

Pravastatin improves endothelial function in arteries used in coronary bypass grafting

Modar Kassan1, María A Sevilla, José M González-Santos

  • 1Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Salamanca, Spain.

Journal of Cardiovascular Pharmacology
|February 23, 2013
PubMed

Insights

Pravastatin incubation improved endothelial function in internal mammary artery and radial artery grafts. This suggests statins may enhance arterial graft performance in coronary artery bypass grafting (CABG) patients.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Biology
  • Pharmacology

Background:

  • Internal mammary artery (IMA) and radial artery (RA) are primary arterial conduits for coronary artery bypass grafting (CABG).
  • Assessing and optimizing arterial graft vasoreactivity is crucial for CABG success.

Purpose of the Study:

  • To compare in vitro vasoreactive properties of IMA and RA.
  • To investigate the impact of pravastatin incubation on the vascular function of IMA and RA.

Main Methods:

  • Organ bath studies were performed on IMA and RA rings from CABG patients.
  • Vascular responses to vasoconstrictors (phenylephrine, U46619) and vasodilators (acetylcholine, sodium nitroprusside) were assessed.
  • Effects of pravastatin and mevalonic acid on vascular reactivity and superoxide anion production were evaluated.

Main Results:

  • RA exhibited greater contractile responses to vasoconstrictors and higher acetylcholine-induced relaxation compared to IMA.
  • Pravastatin incubation reduced U46619-induced contraction and enhanced acetylcholine-mediated relaxation in both arteries.
  • Mevalonic acid abolished pravastatin's effect on vasoconstriction but only partially inhibited its effect on acetylcholine relaxation.

Conclusions:

  • In vitro pravastatin incubation enhances endothelial function in both IMA and RA.
  • Postoperative or intraoperative statin administration may improve arterial graft endothelial function in CABG patients.

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...